Skip to main content
recep.adiyaman
Vision About Experience Education Skills Publications Tools Newsletter Updates Podcasts Blog Contact CV Subscribe
All Issues
Older Newer
Daily Signal April 28, 2026 · 11 min read

Issue #96: Predicting the Mechanism of Action of Bawei Chufan Soup in Treating Teen Depression through Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation.

Protein Design Digest #96: Predicting the Mechanism of Action of Bawei Chufan Soup in Treating Teen…

Share X LinkedIn
Protein Design Daily

Building something in Protein Design?

I love collaborating on new challenges. Let's build together.

LinkedIn Email

Subscribe to Protein Design Digest

Daily curated signals from arXiv, PubMed, and BioRxiv.

Signal of the Day

Predicting the Mechanism of Action of Bawei Chufan Soup in Treating Teen Depression through Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation.

Introduction The Bawei Chufan Soup (BWCFS) in Traditional Chinese Medicine (TCM) offers unique advantages in treating Teen Depression (TD). This study utilizes network pharmacology, molecular docking, and molecular dynamics simulations to predict the material basis and mechanism of action of the decoction. Methods The TCMSP, SwissADME, and SwissTargetPrediction databases were utilized to obtain the active ingredients and targets of the BWCFS. The GeneCards, OMIM, and Disgenet databases were used to identify disease targets, and the intersection of these sets was determined using the VENNY tool. The intersecting targets were imported into the String database for protein- protein interaction analysis and the screening of core targets. GO and KEGG enrichment analyses of the intersecting targets were conducted using the David database, and drugcomponent- target-pathway network diagrams were constructed using Cytoscape 3.10.0 software. The molecular docking models of the core components and key targets were generated using AutoDock Vina, and kinetic simulations were conducted using GROMACS 2020.3, paired with the best docking models. Results After screening, the study identified the core components of BWCFS as Baicalein, Kaempferol, Quercetin, Cerevisterol, and Cavidine, with the key targets for TD being AKT1, IL6, TNF, ESR1, and IL1B. GO enrichment analysis revealed that BWCFS may affect signal transduction in the treatment of TD, and is associated with cellular components such as the plasma membrane and dendrites, as well as the regulation of protein binding. KEGG analysis suggested that the intersecting genes are primarily enriched in the cyclic adenosine monophosphate (cAMP) signaling pathway. Molecular docking results indicated that AKT1 shows good binding affinity with Baicalein, Cavidine, Kaempferol, and Quercetin, while Cerevisterol exhibits strong binding with TNF. The molecular dynamics simulations were stable and reliable. During the protein-ligand complex simulation, the binding between the protein and ligand was stable, with van der Waals interactions as the primary force, while hydrogen bonds were present between both the protein and ligand. Discussion Though this study has several common limitations associated with network pharmacology, and no animal experiments have been conducted for verification, the study has successfully explored and validated the mechanism of action of BWCFS in treating TD using scientific computational methods. This study provides new perspectives and methods for the development and management of pharmacological treatments for TD, offering innovative insights into TCM approaches for its treatment. Conclusion Through network pharmacology, this study preliminarily predicted the material basis and mechanism of action of BWCFS in treating TD. Furthermore, the therapeutic effects of BWCFS on TD may be associated with neuroinflammation and structural and functional changes in neuronal dendrites. The cAMP-PKA-NF-κB and cAMP-PI3K-AKT-NF-κB pathways are proposed as potential therapeutic targets.

Why this matters: Enhances small-molecule or peptide docking accuracy for targeted drug discovery.

Also Worth Reading

Identification of paucinervin D as a natural sphingosine-1-phosphate receptor 1 agonist: Insights from pharmacophore modeling, docking, molecular dynamics simulations, and density functional theory.

Sphingosine-1-phosphate receptor 1 (S1PR1), a member of the G protein-coupled receptor (GPCR) family, is a crucial therapeutic target for various diseases. Activation of S1PR1 has been recognized as an effective therapeutic strategy for multiple sclerosis (MS), inflammatory bowel disease (IBD), and psoriasis. Natural products (NPs) serve as a rich source of bioactive compounds for drug discovery. Here, we aimed to discover novel S1PR1 agonists from NPs via multi-level virtual screening (VS). Using a validated HipHop pharmacophore model, we screened a database containing 54,642 NPs, followed by molecular docking. Based on binding mode analysis, four candidate S1PR1 agonists (NPC323626, NPC264112, NPC469907, and NPC22192) were selected. Subsequent molecular dynamics (MD) simulations and binding free energy calculations confirmed the stability of the receptor-ligand complexes and their binding affinities. Among the four candidates, NPC469907 exhibited the strongest binding affinity for S1PR1, with a value of -58.08 ± 0.13 kJ/mol. Furthermore, hydrogen bonds formed between NPC469907 and Glu121 of S1PR1 were found to be essential for receptor activation. Quantum mechanical calculations further revealed that the phenyl-ring-attached hydrogen site in NPC469907 could be modified without compromising its ability to activate S1PR1. The analysis of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) indicated that NPC469907 possessed favorable pharmacokinetic properties and low toxicity. In conclusion, our study identified NPC469907 as a promising natural S1PR1 agonist and established an effective VS strategy for the discovery of novel S1PR1 agonists.

New Docking, Molecular Dynamics, and QSAR Models to Predict Disruption of Human and Rat Transthyretin Function by Per- and Polyfluoroalkyl Substances (PFAS).

Per- and polyfluoroalkyl substances (PFAS) are environmentally persistent chemicals that require an improved understanding of the toxicity mechanisms and the development of predictive models for risk assessment. One observed effect of PFAS exposure is a decrease in thyroxine (T4) levels in vivo resulting from the direct displacement of T4 from a carrier protein, transthyretin (TTR), in a proposed adverse outcome pathway (AOP). In this study, the mechanism of thyroxine (T4) displacement from human and rat TTRs was investigated by using structural approaches (i.e., docking and molecular dynamics) and quantitative structure-activity relationship (QSAR) models. A QSAR model was developed using the largest available binding data set and a two-tier approach that allowed inclusion of all data. Docking models that utilized a pharmacophore approach showed nearly perfect overlap with independently sourced crystal structures for perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). Molecular dynamics simulations demonstrated similar PFAS binding modes in rat and human TTR, enabling interspecies toxicity comparisons. All models predicted moderate to strong binding of the novel PFAS 4,8-Dioxa-3H-perfluorononanoic acid (ADONA) and hexafluoropropylene oxide dimer acid (GenX) to TTR, consistent with the limited toxicity and binding data for these chemicals. Predicted PFAS binding energies for rat TTR correlated well with the in vivo PFAS-associated decreases in T4 levels, supporting the AOP. The development of reliable predictive toxicity models for PFAS requires extensive validation, maximal use of available experimental data, and careful consideration of toxicokinetic differences in interchemical comparisons.

Molecular docking approaches in mycetoma: Toward improved patient management.

Mycetoma is a neglected tropical disease characterised by chronic, granulomatous inflammation of the subcutaneous tissues, often leading to disfigurement, disability, and significant socioeconomic burdens. Caused by a diverse array of bacterial and fungal pathogens, eumycetoma is predominantly driven by Madurella mycetomatis, and current treatment strategies are limited and often ineffective. Conventional antifungal therapies, such as itraconazole, require prolonged administration, frequently combined with surgical interventions, yet cure rates remain suboptimal, and recurrence is common. The formidable protective grain, comprising microbial material, melanin, and host-derived substances, acts as a physical and biochemical barrier, impeding the penetration and efficacy of drugs. Additionally, issues such as toxicity, resistance, and high costs further complicate management, underscoring the urgent need for novel therapeutic strategies. Recent advancements in computational drug discovery, particularly molecular docking, offer promising avenues to accelerate the identification of effective anti-mycetoma agents. Molecular docking simulates the interaction between small molecules and target proteins, enabling rapid virtual screening of large compound libraries, including natural products, existing drugs, and synthetic molecules, against key pathogenic targets. This structure-based approach helps prioritise candidates with high binding affinity, guiding subsequent experimental validation and reducing both time and financial costs associated with traditional drug development. When integrated with artificial intelligence (AI) and machine learning (ML), these methods can enhance predictive accuracy, uncover novel bioactive scaffolds, and facilitate the repurposing of FDA-approved drugs such as montelukast and vilanterol. Key molecular targets in M. mycetomatis include enzymes and pathways critical for pathogen survival and virulence, notably cytochrome P450 (CYP51), dihydrofolate reductase (DHFR), chitin synthase, melanin biosynthesis pathways, and metal ion acquisition systems. Melanin production, via DHN-melanin, DOPA-melanin, and pyomelanin pathways, contributes to grain pigmentation and structural integrity, while metal ions such as iron and zinc are vital for enzymatic activities, grain formation, and fungal virulence. Disrupting metal ion homeostasis through targeting zincophores, siderophores, and zinc-binding proteins represents a promising therapeutic strategy to weaken grain robustness and enhance drug penetration. Despite the potential of molecular docking, limitations such as reliance on homology models, static protein structures, and the absence of cellular context necessitate complementary approaches, including molecular dynamics simulations and in vitro validation. These combined efforts can refine candidate compounds, optimise binding affinities, and predict pharmacokinetic properties. Furthermore, integrating docking results with clinical data and global collaboration platforms can accelerate the discovery of affordable, effective treatments tailored to endemic regions. In conclusion, leveraging molecular docking and computational methods to target essential M. mycetomatis pathways offers a promising frontier in mycetoma research. By identifying novel inhibitors and understanding pathogen biology at a molecular level, these approaches can inform targeted therapies, reduce treatment durations, and improve patient outcomes. Future research should focus on validating computational predictions experimentally and translating these findings into clinical practice, with an emphasis on accessible, cost-effective interventions for vulnerable populations affected by this neglected disease.

Research & AI Updates

From the Industry

Quick Reads

AlphaFold-Multimer modelling of linked nAChR subunits challenges concatemer design assumptions.

Design of a novel proteome-derived scaffold presenting epitopes of Pseudomonas aeruginosa in native conformation.

Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium that poses a significant threat in nosocomial infections due to its intrinsic resistance to antibiotics and remarkable adaptability. Read more →

Enhanced Properties of Collagen Nanofiber Scaffolds via Chitosan/Polypyrrole/Glutaraldehyde Double-Crosslinking.

To enhance the functionality of collagen (Coll)-based scaffolds, we developed a double-crosslinking strategy incorporating an electroconductive chitosan (Ch) and polypyrrole (Ppy) composite. Read more →

GAN-GA: A Deep-Evolutionary Approach for Synthesizing Functionally Similar Heat Shock Proteins.

De novo protein design has emerged as a transformative approach for generating functional proteins without relying on naturally occurring templates, offering vast potential in biomedical and industrial applications. Read more →

In silico evaluation of selected triterpenes as potential inhibitors of BRAF and BRAFV600E kinases for cancer treatment.

BRAF kinases are involved in cancer cell survival and metastasis. Read more →

Unraveling the refolding dynamics, TLR2 interaction, and immunomodulatory insights of OmpA from Salmonella Typhimurium.

Salmonella enterica serovar Typhimurium is a Gram-negative bacterium that causes gastrointestinal infection and rising antibiotic resistance worldwide. Read more →

Unravelling the therapeutic potential of chrysin against ischemic stroke and post-stroke cognitive impairment: a network pharmacology and in-silico perspective.

Ischemic stroke (IS) is a cerebrovascular disorder that, if left untreated, can lead to secondary neurodegeneration and Post Stroke Cognitive Impairment (PSCI). Read more →

Identifying the potential anti-lung cancer targets of Baicalein using a network pharmacology approach.

Background Lung cancer remains the deadliest malignancy globally. Read more →

Pipeline Tip

Use GPU-accelerated MD refinement to lift model quality in under 2 hours.

Resources & Tools

The protein structure is the language of life; design is its poetry. — Recep Adiyaman

BS HF DK